Just to clarify one point that the CEO stated as regards the...

Just to clarify one point that the CEO stated as regards the manufacturing issue. The current antibody that has recently been made did only fail one of the release tests BUT this failure makes it highly unlikely that the material will ever be used in a clinical trial...unless the Paul Ehrlich Institute in Germany can be persuaded otherwise (he stated that this is unlikely to happen). So, it is likely that new material will need to be produced for a future clinical trial.

The $1mm mentioned would be required to develop a new process to be used in the manufacturing. That would take around a year. Then.......they could start on the actual manufacturing of the antibody again. That would take another year or so (so he said). The cost would obviously depend on how much antibody they made but it would run into the millions, if we go off what was spent on the current production!

So, in this scenario...it will take at least 2 years to get any usable material. That is before getting approval and getting the trial started......so perhaps 2.5 years at least?

I guess the major shareholders are so far under water now that there is no point in selling! After all, 1% of the company (around 7m shares) at 0.7c is only worth $49,000!! Hardly worth the effort.